Gujarat Kidney And Super Speciality (NSE:GKSL) ROC (Joel Greenblatt) %: 31.86% (As of Mar. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
18 GF Score
Price ₹127.39
! 3 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality ROC (Joel Greenblatt) %?

Gujarat Kidney And Super Speciality NSE:GKSL -0.63% 18 ROC (Joel Greenblatt) % is 31.86% as of Mar. 2026, which is 9% below its 10-year median of 34.95. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Gujarat Kidney And Super Speciality ranks better than 79.43% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Gujarat Kidney And Super Speciality's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 31.86%.

The historical rank and industry rank for Gujarat Kidney And Super Speciality's ROC (Joel Greenblatt) % or its related term are showing as below:

NSE:GKSL' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 29.95   Med: 34.95   Max: 41.42
Current: 41.42

During the past 4 years, Gujarat Kidney And Super Speciality's highest ROC (Joel Greenblatt) % was 41.42%. The lowest was 29.95%. And the median was 34.95%.

NSE:GKSL's ROC (Joel Greenblatt) % is ranked better than
79.43% of 666 companies
in the Healthcare Providers & Services industry
Industry Median: 12.47 vs NSE:GKSL: 41.42

Gujarat Kidney And Super Speciality's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Gujarat Kidney And Super Speciality  (NSE:GKSL) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Gujarat Kidney And Super Speciality ROC (Joel Greenblatt) % Related Terms


Gujarat Kidney And Super Speciality ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality ROC (Joel Greenblatt) % Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
ROC (Joel Greenblatt) %
30.92 38.98 29.95 40.02

Gujarat Kidney And Super Speciality Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial 34.92 15.24 97.54 43.11 31.86

NSE:GKSL vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison

For the Medical Care Facilities subindustry, Gujarat Kidney And Super Speciality's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Kidney And Super Speciality ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Gujarat Kidney And Super Speciality's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Gujarat Kidney And Super Speciality's ROC (Joel Greenblatt) % falls into.


NSE:GKSL
18GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Kidney And Super Speciality ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(386.287 + 20.551 + 35.618) - (84.563 + 0 + 44.64)
=313.253

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Gujarat Kidney And Super Speciality for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=220.152/( ( (0 + max(0, 0)) + (377.776 + max(313.253, 0)) )/ 1 )
=220.152/( ( 0 + 691.029 )/ 1 )
=220.152/691.029
=31.86 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 31.86% mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a ROC (Joel Greenblatt) % of 31.86% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Gujarat Kidney And Super Speciality and its competitors. This is near median its historical median of 34.95. Over the past decade, Gujarat Kidney And Super Speciality's ROC (Joel Greenblatt) % has ranged from 29.95 to 41.42. According to the industry distribution chart, Gujarat Kidney And Super Speciality ranks #137 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 20.6%.
Is Gujarat Kidney And Super Speciality's ROC (Joel Greenblatt) % too high?
Gujarat Kidney And Super Speciality's current ROC (Joel Greenblatt) % of 31.86% is near median its 10-year median of 34.95. Over the past 10 years, this metric has ranged from a low of 29.95 to a high of 41.42. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.47. Gujarat Kidney And Super Speciality's value of 31.86% is 155.5% above this industry median. Based on the distribution chart, Gujarat Kidney And Super Speciality ranks #137 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gujarat Kidney And Super Speciality ranks #137 out of 666 companies for ROC (Joel Greenblatt) %. This places Gujarat Kidney And Super Speciality in the top 21% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.47. Gujarat Kidney And Super Speciality's value of 31.86% is 155.5% above this benchmark. Historically, Gujarat Kidney And Super Speciality's own ROC (Joel Greenblatt) % has ranged from 29.95 to 41.42 over the past decade. While the company's 10-year median is 34.95 vs. the industry median of 12.47, Gujarat Kidney And Super Speciality has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current ROC (Joel Greenblatt) % of 31.86% is 155.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Gujarat Kidney And Super Speciality and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current ROC (Joel Greenblatt) % is 31.86%, which is near median its own 10-year median of 34.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current ROC (Joel Greenblatt) % of 31.86%. The current ROC (Joel Greenblatt) % is 31.86%, which is near median its 10-year median of 34.95 and 155.5% above the Healthcare Providers & Services industry median of 12.47. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current ROC (Joel Greenblatt) % is 31.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score

Get the complete analysis for NSE:GKSL

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹127.39
Price